STXS

Stereotaxis, Inc.

$1.03

-9.65%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems.

Source: Yahoo Finance
AI summary

Price & performance

1M-11.0%
3M-24.5%
YTD-54.7%
1Y-62.6%
52-week range—
Beta1.23
Full chart and returns against a benchmark

Q-Score

35/ 100

Quality against peers; 50 is the peer median.

Growth39
Risk51
Performance39
Valuation33
Profitability45
Leverage31
Sentiment48
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$32.4M+20.3%
Net income-$21.6M
Net margin-66.8%+22.5 pts
Historical fundamentals

Revenue exposure

60%of revenue from outside the US
Non Us60%
United States40%
Regions, segments, customers and suppliers

Valuation

STXSIndustryP/E—49.36P/S3.433.73EV/EBITDA—23.12P/B8.433.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate$-0.06
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate